VBI Vaccines Inc reports results for the quarter ended in December - Earnings Summary

VBI Vaccines

13/03/2023 14:01

* VBI Vaccines Inc  VBIV.OQ  reported a quarterly adjusted
loss
of 8 cents​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of 7 cents per share.
    * Revenue rose 261.7% to $293.00 thousand from a year ago;
analysts expected $1.98 million. 
    * VBI Vaccines Inc's reported EPS for the quarter was a loss
of 8
cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * VBI Vaccines Inc shares had fallen by 11.1% this quarter.
    * The company reported a quarterly loss of $21.14 million.
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $4.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 13 at 02:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.07          -0.08          Missed
 Sep. 30 2022      -0.08          -0.09          Missed
 Jun. 30 2022      -0.07          -0.18          Missed
 Mar. 31 2022      -0.08          -0.08          Met